东京热福利视频导航|日韩无码不卡一区|成人高清手机在线|在厨房乱子伦对白一区二区|中文字幕网址导航|国产原创在线亚洲黄色大片高清无码|深爱激情五月丁香亚洲综合社区|成人在线手机视频|浮力影院成人A片|日韩限制电影在线观看

Bioengineering
  • 數(shù)據(jù)庫收錄SCIE
  • 創(chuàng)刊年份2014年
  • 年發(fā)文量0

Bioengineering

期刊中文名:生物工程ISSN:2306-5354

該雜志國際簡稱:Bioengineering,是由出版商Multidisciplinary Digital Publishing Institute (MDPI)出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以ENGINEERING, BIOMEDICAL研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進(jìn)展,選載對學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。

基本信息:
期刊簡稱:Bioengineering
是否OA:開放
是否預(yù)警:
Gold OA文章占比:95.36%
出版信息:
出版地區(qū):Switzerland
出版周期:Monthly
出版語言:English
出版商:Multidisciplinary Digital Publishing Institute (MDPI)
評價信息:
中科院分區(qū):3區(qū)
CiteScore:4
雜志介紹 中科院JCR分區(qū) JCR分區(qū) CiteScore 投稿經(jīng)驗(yàn)

雜志介紹

Bioengineering雜志介紹

《Bioengineering》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱生物工程,本刊主要出版、報道醫(yī)學(xué)-ENGINEERING, BIOMEDICAL領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認(rèn)可。最新CiteScore 指數(shù)為4。

本刊近期中國學(xué)者發(fā)表的論文主要有:

  • Hybrid Therapeutic Device (CUHK-OA-M2) for Relieving Symptoms Induced by Knee Osteoarthritis

    Author: Zou, Li; Chu, Kisum; He, Xuan; Li, Ye; Zhou, Liangbin; Xu, Xiayi; Liao, Wei-Hsin; Qin, Ling

  • Automatic Segmentation of Cervical Cells Based on Star-Convex Polygons in Pap Smear Images

    Author: Zhao, Yanli; Fu, Chong; Zhang, Wenchao; Ye, Chen; Wang, Zhixiao; Ma, Hong-feng

  • The Bionic High-Cushioning Midsole of Shoes Inspired by Functional Characteristics of Ostrich Foot

    Author: Zhang, Rui; Zhao, Liangliang; Kong, Qingrui; Yu, Guolong; Yu, Haibin; Li, Jing; Tai, Wei-Hsun

  • Plant Exosome-like Nanoparticles as Biological Shuttles for Transdermal Drug Delivery

    Author: Wang, Ye; Wei, Yongsheng; Liao, Hui; Fu, Hongwei; Yang, Xiaobin; Xiang, Qi; Zhang, Shu

英文介紹

Bioengineering雜志英文介紹

Aims

Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:

● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.

● Manuscripts regarding research proposals and research ideas will be particularly welcomed.

● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.

● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.

Scope

● Bionics and biological cybernetics: implantology; bio–abio interfaces

● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices

● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.

● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology

● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering

● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation

● Translational bioengineering

中科院SCI分區(qū)

Bioengineering雜志中科院分區(qū)信息

2023年12月升級版
綜述:
TOP期刊:
大類:醫(yī)學(xué) 3區(qū)
小類:

ENGINEERING, BIOMEDICAL
工程:生物醫(yī)學(xué) 4區(qū)

2022年12月升級版
綜述:
TOP期刊:
大類:工程技術(shù) 3區(qū)
小類:

ENGINEERING, BIOMEDICAL
工程:生物醫(yī)學(xué) 3區(qū)

中科院SCI分區(qū):是中國科學(xué)院文獻(xiàn)情報中心科學(xué)計量中心的科學(xué)研究成果。期刊分區(qū)表自2004年開始發(fā)布,延續(xù)至今;2019年推出升級版,實(shí)現(xiàn)基礎(chǔ)版、升級版并存過渡,2022年只發(fā)布升級版,期刊分區(qū)表數(shù)據(jù)每年底發(fā)布。 中科院分區(qū)為4個區(qū)。中科院分區(qū)采用刊物前3年影響因子平均值進(jìn)行分區(qū),即前5%為該類1區(qū),6%~20%為2區(qū)、21%~50%為3區(qū),其余的為4區(qū)。1區(qū)和2區(qū)雜志很少,雜志質(zhì)量相對也高,基本都是本領(lǐng)域的頂級期刊。

JCR分區(qū)(2023-2024年最新版)

Bioengineering雜志 JCR分區(qū)信息

按JIF指標(biāo)學(xué)科分區(qū)

JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨(dú)特的多學(xué)科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個具體學(xué)科。JCR分區(qū)根據(jù)每個學(xué)科分類按照期刊當(dāng)年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。

CiteScore 評價數(shù)據(jù)(2024年最新版)

Bioengineering雜志CiteScore 評價數(shù)據(jù)

  • CiteScore 值:4
  • SJR:0.627
  • SNIP:0.896
學(xué)科類別 分區(qū) 排名 百分位
大類:Chemical Engineering 小類:Bioengineering Q3 104 / 162

36%

歷年影響因子和期刊自引率

投稿經(jīng)驗(yàn)

Bioengineering雜志投稿經(jīng)驗(yàn)

該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學(xué)術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在ENGINEERING, BIOMEDICAL綜合專業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高,對稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 first decision approximately 15.9 days after submission; acceptance to publication is undertaken in 3.7 days ,如果想投稿該刊要做好時間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

免責(zé)聲明

若用戶需要出版服務(wù),請聯(lián)系出版商:MDPI, ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052。